The Journal of pediatrics
-
The Journal of pediatrics · Aug 2005
Randomized Controlled Trial Multicenter Study Comparative Study Clinical TrialComparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
To evaluate efficacy, safety, health outcomes, and cost-effectiveness of fluticasone propionate (FP) versus montelukast (MON) in 342 children (6 to 12 years of age) with persistent asthma. ⋯ FP was significantly more effective than MON in improving pulmonary function, asthma symptoms, and rescue albuterol use. Both therapies had similar safety profiles. Parent- and physician-reported satisfaction ratings were higher with FP treatment, and asthma-related costs were lower.